Source: FiercePharma

DelSiTech: Seeking to shake up eye inflammation market, Optifye and DelSiTech partner on controlled-release drops

Seeking to shake up eye inflammation market, Optifye and DelSiTech partner on controlled-release drops ntaylor Tue, 03/29/2022 - 06:30

Read full article »
DelSiTech's Competitors | DelSiTech's News | DelSiTech's Financials
Stay up-to-date with the latest news on DelSiTech
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Lasse Leino's photo - President & CEO of DelSiTech

President & CEO

Lasse Leino

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on DelSiTech